First GLP-1 implant approval in the EU by 2030 Q1
Resolves: EMA or another EU regulatory body issues a positive opinion or full approval for the semaglutide implant (NPM-139) for weight maintenance in adults based on submitted clinical and safety data.
user-generated· regulatory
First GLP-1 implant approval in the EU by 2030 Q1
Market overview
A regulatory agency in the European Union will grant market authorization to Vivani Medical’s semaglutide implant for weight maintenance therapy by March 31, 2030. This would mark the first approved GLP-1 implant globally, validating the technology’s viability.
regulatory prediction market
- Implied probability (Yes)
- 35%
- Closes
- 2030-03-31
About this prediction
Resolution criteria
EMA or another EU regulatory body issues a positive opinion or full approval for the semaglutide implant (NPM-139) for weight maintenance in adults based on submitted clinical and safety data.
Source: user-generated
More regulatory markets
- Mechanical Turk fully shuts down by December 31, 2026 — 85% Yes
- Tougher bail bill for GBV offenders tabled — 48% Yes
- UK government launches inquiry into Premier League governance — 70% Yes
- Norway resumes missile supply to Malaysia by August 2026 — 70% Yes
- African governments will regulate influencer news content by 2028 — 80% Yes
- UK enforces mandatory cosmetic injectable qualifications by 2027 — 80% Yes
- SEC revises retail private market rules by Q2 2027 — 60% Yes
- Other states pass similar AI firing bans within 12 months — 70% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…